Association between KRAS rs61764370 and triple-negative breast cancer—a false positive? – Authors’ reply - 03/08/11
Doi : 10.1016/S1470-2045(11)70163-2
Joanne Weidhaas a 
, Frank Slack b, Nicola Miller g, Lyndsay Harris c, David Tuck d, Yong Zhu e, Daniel Zelterman e, Michael Kerin g, Trupti Paranjape a, Helen Heneghan g, Robert Lindner h, Florence Keane f, Jemima Dorairaj g, Kimberly Geyda c, Cory Pelletier a, Sunitha Nallur a
, Frank Slack b, Nicola Miller g, Lyndsay Harris c, David Tuck d, Yong Zhu e, Daniel Zelterman e, Michael Kerin g, Trupti Paranjape a, Helen Heneghan g, Robert Lindner h, Florence Keane f, Jemima Dorairaj g, Kimberly Geyda c, Cory Pelletier a, Sunitha Nallur a a Department of Therapeutic Radiology, Yale University, New Haven, CT, USA
b Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA
c Department of Medical Oncology, Yale University, New Haven, CT, USA
d Department of Pathology, Yale University, New Haven, CT, USA
e Department of Public Health, Yale University, New Haven, CT, USA
f Yale Medical School, Yale University, New Haven, CT, USA
g Department of Surgery, Clinical Science Institute, National University of Ireland, Galway, Ireland
h Institute for Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany
Le texte complet de cet article est disponible en PDF.
© 2011
Elsevier Ltd. Tous droits réservés.
Vol 12 - N° 8
P. 724 - août 2011 Retour au numéro
Article précédent
- Association between KRAS rs61764370 and triple-negative breast cancer—a false positive?
- Paul Pharoah, Antonis Antoniou, Andrew Berchuck, Georgia Chenevix-Trench, Simon Gayther, Ellen Goode, Roger Milne, Tom Sellers, Jonathan Tyrer
- Japan’s nuclear crisis
- Kazuhiro Yoshiuchi, Akira Akabayashi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?